Topical Therapy for Osteoarthritis: Clinical and Pharmacologic Perspectives

References

• . Dahaghin S, Bierma-Zeinstra SM, Ginai AZ, Pols HA, Hazes JM, Koes BW. Prevalence and pattern of radiographic hand osteoarthritis and association with pain and disability (the Rotterdam study). Ann Rheum Dis. 2005;64(5):682–687
   PubMed Web of Science ®Google Scholar
• . Dawson J, Linsell L, Zondervan K,. Impact of persistent hip or knee pain on overall health status in elderly people: a longitudinal population study. Arthritis Rheum. 2005;53(3):368–374
   PubMedGoogle Scholar
• . Dawson J, Linsell L, Zondervan K,. Epidemiology of hip and knee pain and its impact on overall health status in older adults. Rheumatology (Oxford). 2004;43(4):497–504
   PubMed Web of Science ®Google Scholar
• . Lawrence RC, Helmick CG, Arnett FC,. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–799
   PubMed Web of Science ®Google Scholar
• . Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum. 1995;38(8):1134–1141
   PubMed Web of Science ®Google Scholar
• . Arden N, Nevitt MC. Osteoarthritis: epidemiology. Best Pract Res Clin Rheumatol. 2006;20(1):3–25
   PubMed Web of Science ®Google Scholar
• . Malemud CJ, Islam N, Haqqi TM. Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells Tissues Organs. 2003;174(1-2):34–48
   PubMed Web of Science ®Google Scholar
• . Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P, Felson DT. Prevalence of symptomatic hand osteoarthritis and its impact on functional status among the elderly: The Framingham Study. Am J Epidemiol. 2002;156(11):1021–1027
   PubMed Web of Science ®Google Scholar
• . Brooks PM. Impact of osteoarthritis on individuals and society: how much disability? Social consequences and health economic implications. Curr Opin Rheumatol. 2002;14(5):573–577
   PubMed Web of Science ®Google Scholar
• . Guccione AA, Felson DT, Anderson JJ,. The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health. 1994;84(3):351–358
   PubMed Web of Science ®Google Scholar
• . McKenna MT, Michaud CM, Murray CJ, Marks JS. Assessing the burden of disease in the United States using disability-adjusted life years. Am J Prev Med. 2005;28(5):415–423
   PubMed Web of Science ®Google Scholar
• . Kallman DA, Wigley FM, Scott WW Jr, Hochberg MC, Tobin JD. The longitudinal course of hand osteoarthritis in a male population. Arthritis Rheum. 1990;33(9):1323–1332
   PubMedGoogle Scholar
• . Peat G, Thomas E, Handy J,. The Knee Clinical Assessment Study-CAS(K). A prospective study of knee pain and knee osteoarthritis in the general population: baseline recruitment and retention at 18 months. BMC Musculoskelet Disord. 2006;7:30
   PubMed Web of Science ®Google Scholar
• . Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43(9):1905–1915
   PubMed Web of Science ®Google Scholar
• . American Pain Society. Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 5th ed. Glenview, IL: American Pain Society; 2003
   Google Scholar
• . Jordan KM, Arden NK, Doherty M,; Standing Committee for International Clinical Studies Including Therapeutic Trials ESCISIT. EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis. 2003;62(12):1145–1155
   PubMed Web of Science ®Google Scholar
• . Zhang W, Doherty M, Leeb BF,; ESCIST. EULAR evidence-based recommendations for the diagnosis of hand osteoarthritis-report of a task force of ESCISIT. Ann Rheum Dis. 2009;68(1):8–17
   PubMed Web of Science ®Google Scholar
• . Zhang W, Moskowitz RW, Nuki G,. OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage. 2007;15(9):981–1000
   PubMed Web of Science ®Google Scholar
• . Gabriel SE, Jaakkimainen L, Bombardier C. Risk for serious gastrointestinal complications related to use of nonsteroidal anti-inflammatory drugs. A meta-analysis. Ann Intern Med. 1991;115(10):787–796
   PubMed Web of Science ®Google Scholar
• . Evans JM, McMahon AD, McGilchrist MM,. Topical non-steroidal anti-inflammatory drugs and admission to hospital for upper gastrointestinal bleeding and perforation: a record linkage case-control study. BMJ. 1995;311(6996):22–26
   PubMed Web of Science ®Google Scholar
• . Motsko SP, Rascati KL, Busti AJ,. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf. 2006;29(7):621–632
   PubMed Web of Science ®Google Scholar
• . Hermann M, Ruschitzka F. Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs. Ann Med. 2007;39(1):18–27
   PubMed Web of Science ®Google Scholar
• . Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med. 2006;99(3):132–140
   PubMed Web of Science ®Google Scholar
• . Juni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364(9450):2021–2029
   PubMed Web of Science ®Google Scholar
• . Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Metaanalysis of randomised trials. BMJ. 2006;332(7553):1302–1308
   PubMed Web of Science ®Google Scholar
• . Barkin RL, Buvanendran A. Focus on the COX-1 and COX-2 agents: renal events of nonsteroidal and anti-inflammatory drugs-NSAIDs. Am J Ther. 2004;11(2):124–129
   PubMedGoogle Scholar
• . Evans JM, McGregor E, McMahon AD,. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM. 1995;88(8):551–557
   PubMed Web of Science ®Google Scholar
• . Laine L, Goldkind L, Curtis SP, Connors LG, Yanqiong Z, Cannon CP. How common is diclofenac-associated liver injury? Analysis of 17 289 arthritis patients in a long-term prospective clinical trial. Am J Gastroenterol. 2009;104(2):356–362
   PubMed Web of Science ®Google Scholar
• . Schnitzer TJ. Update of ACR guidelines for osteoarthritis: role of the coxibs. J Pain Symptom Manage. 2002;23( suppl 4):S24–S30; discussion S31–S24
   PubMed Web of Science ®Google Scholar
• . Cordero JA, Camacho M, Obach R, Domenech J, Vila L. In vitro based index of topical anti-inflammatory activity to compare a series of NSAIDs. Eur J Pharm Biopharm. 2001;51(2):135–142
   PubMed Web of Science ®Google Scholar
• . Riess W, Schmid K, Botta L,. [The percutaneous absorption of diclofenac]. Arzneimittelforschung. 1986;36(7):1092–1096
   PubMed Web of Science ®Google Scholar
• . Kienzler JL, Ducarme X, Gold M. Comparative bioavailability of topical diclofenac sodium gel 1% and oral diclofenac sodium in healthy volunteers: a steady-state, randomized, crossover systemic study. Presented at: Osteoarthritis Research International World Congress on Osteoarthritis; December 6–9, 2007; Fort Lauderdale, FL
   Google Scholar
• . Mason L, Moore RA, Edwards JE, Derry S, McQuay HJ. Topical NSAIDs for chronic musculoskeletal pain: systematic review and meta-analysis. BMC Musculoskelet Disord. 2004;5:28
   PubMed Web of Science ®Google Scholar
• . Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. J Rheumatol. 2004;31(10):2002–2012
   PubMed Web of Science ®Google Scholar
• . Altman R, Zacher J, Renee LD,. Efficacy and safety of diclofenac sodium gel 1% in patients with osteoarthritis of the hand: a prospective, 8-week, randomized, double-blind, vehicle-controlled, multicenter, phase 3 trial. Presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting; November 6–11, 2007; Boston, MA
   Google Scholar
• . Barthel HR, Haselwood D, Parikh P, Gold M. Efficacy and safety of diclofenac sodium gel 1% in patients with osteoarthritis of the knee: a prospective, 12-week, randomized, double-blind, vehicle-controlled, multicenter, phase 3 trial. Presented at: American College of Rheumatology/Association of Rheumatology Health Professionals Annual Scientific Meeting; November 6–11, 2007; Boston, MA
   Google Scholar
• . Tubach F, Ravaud P, Baron G,. Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement. Ann Rheum Dis. 2005;64(1):29–33
   PubMed Web of Science ®Google Scholar
• . Lin J, Zhang W, Jones A, Doherty M. Efficacy of topical non-steroidal anti-inflammatory drugs in the treatment of osteoarthritis: meta-analysis of randomised controlled trials. BMJ. 2004;329(7461):324
   PubMed Web of Science ®Google Scholar
• . Moore RA, Tramer MR, Carroll D, Wiffen PJ, McQuay HJ. Quantitative systematic review of topically applied non-steroidal anti-inflammatory drugs. BMJ. 1998;316(7128):333–338
   PubMed Web of Science ®Google Scholar
• . Altman R, Zacher J, Dreiser RL. Efficacy and safety of diclofenac sodium gel 1% in patients with OA of the hand: a prospective, 8-week, randomized, double-blind, vehicle-controlled, multicenter, phase 3 trial [poster 288]. Presented at: American College of Rheumatology Annual Meeting; November 6–11, 2007b; Boston, MA
   Google Scholar
• . Mason L, Moore RA, Edwards JE, McQuay HJ, Derry S, Wiffen PJ. Systematic review of efficacy of topical rubefacients containing salicylates for the treatment of acute and chronic pain. BMJ. 2004;328(7446):995
   PubMed Web of Science ®Google Scholar
• . Tegeder I, Pfeilschifter J, Geisslinger G. Cyclooxygenase-independent actions of cyclooxygenase inhibitors. FASEB J. 2001;15(12):2057–2072
   PubMed Web of Science ®Google Scholar
• . Furst DE. Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1994;37(1):1–9
   PubMedGoogle Scholar
• . Singh P, Roberts MS. Dermal and underlying tissue pharmacokinetics of salicylic acid after topical application. J Pharmacokinet Biopharm. 1993;21(4):337–373
   PubMedGoogle Scholar
• . Singh P, Roberts MS. Skin permeability and local tissue concentrations of nonsteroidal anti-inflammatory drugs after topical application. J Pharmacol Exp Ther. 1994;268(1):144–151
   PubMed Web of Science ®Google Scholar
• . Morra P, Bartle WR, Walker SE, Lee SN, Bowles SK, Reeves RA. Serum concentrations of salicylic acid following topically applied salicylate derivatives. Ann Pharmacother. 1996;30(9):935–940
   PubMed Web of Science ®Google Scholar
• . Chan TY. Potential dangers from topical preparations containing methyl salicylate. Hum Exp Toxicol. 1996;15(9):747–750
   PubMed Web of Science ®Google Scholar
• . Bell AJ, Duggin G. Acute methyl salicylate toxicity complicating herbal skin treatment for psoriasis. Emerg Med (Fremantle). 2002;14(2):188–190
   PubMedGoogle Scholar
• . Davies MG, Briffa DV, Greaves MW. Systemic toxicity from topically applied salicylic acid. BMJ. 1979;1(6164):661
   PubMedGoogle Scholar
• . Péc J, Strmenová M, Palencarová E,. Salicylate intoxication after use of topical salicylic acid ointment by a patient with psoriasis. Cutis. 1992;50(4):307–309
   PubMed Web of Science ®Google Scholar
• . Associated Press. Muscle-pain reliever is blamed for Staten Island Runner's death. New York Times. June 10, 2007; New York/Region
   Google Scholar
• . Heng MC. Local necrosis and interstitial nephritis due to topical methyl salicylate and menthol. Cutis. 1987;39(5):442–444
   PubMed Web of Science ®Google Scholar
• . Tanen DA, Danish DC, Reardon JM, Chisholm CB, Matteucci MJ, Riffenburgh RH. Comparison of oral aspirin versus topical applied methyl salicylate for platelet inhibition. Ann Pharmacother. 2008;42(10):1396–1401
   PubMed Web of Science ®Google Scholar
• . Davis JE. Are one or two dangerous? Methyl salicylate exposure in toddlers. J Emerg Med. 2007;32(1):63–69
   PubMed Web of Science ®Google Scholar
• . Chan TY. The risk of severe salicylate poisoning following the ingestion of topical medicaments or aspirin. Postgrad Med J. 1996;72(844):109–112
   PubMed Web of Science ®Google Scholar
• . Yip AS, Chow WH, Tai YT, Cheung KL. Adverse effect of topical methylsalicylate ointment on warfarin anticoagulation: an unrecognized potential hazard. Postgrad Med J. 1990;66(775):367–369
   PubMed Web of Science ®Google Scholar
• . Joss JD, LeBlond RF. Potentiation of warfarin anticoagulation associated with topical methyl salicylate. Ann Pharmacother. 2000; 34(6):729–733
   PubMed Web of Science ®Google Scholar
• . Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328(7446):991
   PubMed Web of Science ®Google Scholar
• . Nolano M, Simone DA, Wendelschafer-Crabb G, Johnson T, Hazen E, Kennedy WR. Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation. Pain. 1999;81(1–2):135–145
   PubMed Web of Science ®Google Scholar
• . Altman RD, Aven A, Holmburg CE,. Capsaicin cream 0.025% as monotherapy for osteoarthritis: a double-blind study. Semin Arthritis Rheum. 1994;23( suppl 3):25–33
   Google Scholar
• . McCarthy GM, McCarty DJ. Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol. 1992;19(4):604–607
   PubMed Web of Science ®Google Scholar
• . Baron R. Capsaicin and nociception: from basic mechanisms to novel drugs. Lancet. 2000;356(9232):785–787
   PubMed Web of Science ®Google Scholar
• . Bruhlmann P, de Vathaire F, Dreiser RL, Michel BA. Short-term treatment with topical diclofenac epolamine plaster in patients with symptomatic knee osteoarthritis: pooled analysis of two randomised clinical studies. Curr Med Res Opin. 2006;22(12):2429–2438
   PubMed Web of Science ®Google Scholar
• . Niethard FU, Gold MS, Solomon GS,. Efficacy of topical diclofenac diethylamine gel in osteoarthritis of the knee. J Rheumatol. 2005;32(12):2384–2392
   PubMed Web of Science ®Google Scholar
• . Roth SH, Shainhouse JZ. Efficacy and safety of a topical diclofenac solution (Pennsaid) in the treatment of primary osteoarthritis of the knee: a randomized, double-blind, vehicle-controlled clinical trial. Arch Intern Med. 2004;164(18):2017–2023
   PubMedGoogle Scholar
• . Rother M, Lavins BJ, Kneer W,. Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial. Ann Rheum Dis. 2007;66(9):1178–1183
   PubMed Web of Science ®Google Scholar
• . Kozanoglu E, Basaran S, Guzel R, Guler-Uysal F. Short term efficacy of ibuprofen phonophoresis versus continuous ultrasound therapy in knee osteoarthritis. Swiss Med Wkly. 2003;133(23–24):333–338
   PubMed Web of Science ®Google Scholar
• . Trnavsky K, Fischer M, Vögtle-Junkert U, Schreyger F. Efficacy and safety of 5% ibuprofen cream treatment in knee osteoarthritis. Results of a randomized, double-blind, placebo-controlled study. J Rheumatol. 2004;31(3):565–572
   PubMed Web of Science ®Google Scholar
• . Underwood M, Ashby D, Cross P,. Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study. BMJ. 2008;336(7636):138–142
   PubMed Web of Science ®Google Scholar
• . Voltaren Gel 1%. [package insert]. Parsippany, NJ: Novartis Consumer Health, Inc; 2007
   Google Scholar